In Vitro Susceptibility of Triple Negative Breast Cancer Cells to Docetaxel, Epirubicin and Carboplatin
AuthID
P-003-5YZ
P-003-5YZ
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service